Error detection thresholds for routine real time in vivo dosimetry in HDR prostate brachytherapy

被引:10
|
作者
Mason, Josh [1 ,2 ]
Henry, Ann [1 ,3 ]
Bownes, Peter [1 ]
机构
[1] Leeds Canc Ctr, Leeds, W Yorkshire, England
[2] Imperial Coll Healthcare NHS Trust, London, England
[3] Univ Leeds, Leeds, W Yorkshire, England
关键词
In vivo dosimetry; Prostate brachytherapy; DOSE-RATE BRACHYTHERAPY; VERIFICATION; CANCER;
D O I
10.1016/j.radonc.2020.04.058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Routine real time in vivo dosimetry (IVD) is performed in HDR prostate brachytherapy to independently verify dose delivery. This study investigates impact of position uncertainty on error detection thresholds for IVD. Methods: IVD is implemented using a microMOSFET placed centrally in the prostate using an additional needle. 144 IVD measurements were made for 15 Gy or 19 Gy single fraction treatments. Needle insertion and treatment planning used real-time trans-rectal ultrasound. Source-MOSFET position thresholds of +/- 1, +/- 2 and +/- 3 mm were used to calculate per-needle and total plan error detection thresholds for the measured dose using an uncertainty analysis based on the treatment plan data. Results: The median dose difference from 144 total plan measurements was -5.2% (range +7.4% to - 17.3%). 3 plans measured outside the total plan error detection threshold for position threshold +/- 1 mm, no plans measured outside the total plan error detection threshold for larger position thresholds. For 2233 individual needle measurements, for position thresholds of +/- 1 mm, +/- 2mm and +/- 3 mm the number of needles outside the per-needle error detection threshold was 103, 25 and 10 respectively and the number of treatments that would have required interruption based on these thresholds for real-time IVD was 66, 16 and 8 respectively. Conclusion: IVD in HDR prostate brachytherapy using a microMOSFET provides a high level of confidence that we are correctly delivering the planned dose to our patients. A +/- 2-3 mm position threshold gives an appropriate balance between error detection and avoiding unnecessary treatment interruptions. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 50 条
  • [31] Urethral in vivo dosimetry in HDR prostate brachytherapy with Ir-192 and Co-60 sources
    Rodriguez Latorre, D. R. L.
    Jose Fernandez, J. F.
    Rivero, G. F. R. Gema F.
    Diego Crelgo, D. C.
    Manuel Gonzalez, J. M. G. Jose
    Pedro Sanchez, P. S.
    Alfonso Villace, A. V.
    Elena Sanchez, E. S.
    Angeles Arroyo, M. A. A. Maria
    Ester Garcia, E. G.
    Ester Trabanco, E. T.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S86 - S87
  • [32] IViST: A Platform for Real-Time In Vivo Source Tracking in HDR Brachytherapy
    Rosales, H. Linares
    Johansen, J.
    Cantin, A.
    Kertzscher, G.
    Archambault, L.
    Tanderup, K.
    Beaulieu, L.
    Beddar, S.
    MEDICAL PHYSICS, 2019, 46 (06) : E494 - E494
  • [33] A multi-sensor-based dosimetry platform for real time source tracking in HDR brachytherapy
    Rosales, H. M. Linares
    Johansen, J.
    Kertzscher, G.
    Tanderup, K.
    Beaulieu, L.
    Beddar, S.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S51 - S51
  • [34] Studies on optical fiber dosimeters for in-vivo dosimetry in HDR brachytherapy
    Moutinho, L.
    Freitas, H.
    Melo, J.
    Veloso, J. F. C. A.
    Rachinhas, P. J.
    Simoes, P. C. P. S.
    Santos, J. A. M.
    Pereira, A.
    Silva, J.
    Pinto, S.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S424 - S425
  • [35] Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy
    Andersen, Claus E.
    Nielsen, Soren Kynde
    Lindegaard, Jacob Christian
    Tanderup, Kari
    MEDICAL PHYSICS, 2009, 36 (11) : 5033 - 5043
  • [36] Error analysis and exactitude standards in HDR brachytherapy of prostate cancer
    Baltas, Q.
    Anagnostopoulos, G.
    Gebrebrahan, D.
    Milickovic, N.
    Zamboglou, N.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 115 - 116
  • [37] RESULTS OF AN ERROR SIMULATION STUDY FOR HDR BRACHYTHERAPY IMPLANTS OF PROSTATE
    Baltas, D.
    Katsilieri, Z.
    Kefala, V.
    Papaioannou, S.
    Zamboglou, N.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S13 - S13
  • [38] Can we predict final dose distribution in real time prostate HDR brachytherapy?
    Szlag, M.
    Rembielak, A.
    Bialas, B.
    Fijalkowski, M.
    Bystrzycka, J.
    Slosarek, K.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S504 - S505
  • [39] The influence of the dwell time deviation constraint (DTDC) parameter on dosimetry with IPSA optimisation for HDR prostate brachytherapy
    Ryan L. Smith
    Vanessa Panettieri
    Craig Lancaster
    Natasha Mason
    Rick D. Franich
    Jeremy L. Millar
    Australasian Physical & Engineering Sciences in Medicine, 2015, 38 : 55 - 61
  • [40] The influence of the dwell time deviation constraint (DTDC) parameter on dosimetry with IPSA optimisation for HDR prostate brachytherapy
    Smith, Ryan L.
    Panettieri, Vanessa
    Lancaster, Craig
    Mason, Natasha
    Franich, Rick D.
    Millar, Jeremy L.
    AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE, 2015, 38 (01) : 55 - 61